Glycine-Binding Site Stimulants of NMDA Receptors Alleviate Extrapyramidal Motor Disorders by Activating the Nigrostriatal Dopaminergic Pathway
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glycine-Binding Site Stimulants of NMDA Receptors Alleviate Extrapyramidal Motor Disorders by Activating the Nigrostriatal Dopaminergic Pathway
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 18, Issue 7, Pages 1416
Publisher
MDPI AG
Online
2017-07-03
DOI
10.3390/ijms18071416
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacotherapeutic strategies in the treatment of severe Alzheimer’s disease
- (2016) William James Deardorff et al. EXPERT OPINION ON PHARMACOTHERAPY
- Modulating NMDA Receptor Function with d-Amino Acid Oxidase Inhibitors: Understanding Functional Activity in PCP-Treated Mouse Model
- (2016) Henry Sershen et al. NEUROCHEMICAL RESEARCH
- Effects of sodium benzoate on pre-pulse inhibition deficits and hyperlocomotion in mice after administration of phencyclidine
- (2015) Akiko Matsuura et al. ACTA NEUROPSYCHIATRICA
- Interaction between anti-Alzheimer and antipsychotic drugs in modulating extrapyramidal motor disorders in mice
- (2015) Saki Shimizu et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Atypical antipsychotic properties of AD-6048, a primary metabolite of blonanserin
- (2015) Ayaka Tatara et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Effects of sodium benzoate on pre-pulse inhibition deficits and hyperlocomotion in mice after administration of phencyclidine
- (2015) Akiko Matsuura et al. ACTA NEUROPSYCHIATRICA
- The Role of Ketamine in Treatment-Resistant Depression: A Systematic Review
- (2014) Gianluca Serafini et al. Current Neuropharmacology
- Schizophrenia: from dopaminergic to glutamatergic interventions
- (2014) Marc Laruelle CURRENT OPINION IN PHARMACOLOGY
- NMDA receptor structures reveal subunit arrangement and pore architecture
- (2014) Chia-Hsueh Lee et al. NATURE
- d-Cycloserine augmentation of cognitive remediation in schizophrenia
- (2014) Christopher K. Cain et al. SCHIZOPHRENIA RESEARCH
- Pathophysiological Roles of Serotonergic System in Regulating Extrapyramidal Motor Functions
- (2013) Yukihiro Ohno et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Improving the Treatment of Schizophrenia: Role of 5-HT Receptors in Modulating Cognitive and Extrapyramidal Motor Functions
- (2013) Saki Shimizu et al. CNS & Neurological Disorders-Drug Targets
- 5-HT1A agonist alleviates serotonergic potentiation of extrapyramidal disorders via postsynaptic mechanisms
- (2013) Saki Shimizu et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Add-on Treatment of Benzoate for Schizophrenia
- (2013) Hsien-Yuan Lane et al. JAMA Psychiatry
- d-Serine Regulates Proliferation and Neuronal Differentiation of Neural Stem Cells from Postnatal Mouse Forebrain
- (2012) Xu Huang et al. CNS Neuroscience & Therapeutics
- D-Cycloserine: An Evolving Role in Learning and Neuroplasticity in Schizophrenia
- (2012) D. C. Goff SCHIZOPHRENIA BULLETIN
- NMDA Receptor and Schizophrenia: A Brief History
- (2012) J. T. Coyle SCHIZOPHRENIA BULLETIN
- Recent Advances in the Discovery of D-Amino Acid Oxidase Inhibitors and Their Therapeutic Utility in Schizophrenia
- (2011) Dana V. Ferraris et al. CURRENT PHARMACEUTICAL DESIGN
- Therapeutic Role of 5-HT1A Receptors in The Treatment of Schizophrenia and Parkinson's Disease
- (2010) Yukihiro Ohno CNS Neuroscience & Therapeutics
- Role of cortical and striatal 5-HT1A receptors in alleviating antipsychotic-induced extrapyramidal disorders
- (2010) Saki Shimizu et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Anticataleptic 8-OH-DPAT preferentially counteracts with haloperidol-induced Fos expression in the dorsolateral striatum and the core region of the nucleus accumbens
- (2008) Yukihiro Ohno et al. NEUROPHARMACOLOGY
- Once-weekly d-cycloserine effects on negative symptoms and cognition in schizophrenia: An exploratory study
- (2008) D GOFF et al. SCHIZOPHRENIA RESEARCH
- The microinjection of AMPA receptor antagonist into the accumbens shell, but not into the accumbens core, induces anxiolysis in an animal model of anxiety
- (2007) Isabel Cristina da Cunha et al. BEHAVIOURAL BRAIN RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now